Quetiapine Fumarate XR Tablets

Notice ID:SPE2D223R0010

Amendment 0003 SPE2D2-23-R-0010 issued May 2, 2023 to extend the closing date from May 5, 2023 3:00 PM EDT to May 19, 2023 3:00 PM EDT. Amendment 0002 SPE2D2-23-R-0010 issued April 18, 2023 to extend ...

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY (DLA) DLA TROOP SUPPORT
  PSC   DRUGS AND BIOLOGICALS


Data sourced from SAM.gov. View Official Posting »

Quetiapine Fumarate XR Tablets

Notice ID:SPE2D223R0010

The Defense Logistics Agency plans a national requirements contract for Quetiapine Fumarate XR Tablets in five specified strengths. The firm-fixed price contract will have a one-year base period and four one-year option periods. It will establish a national supply source for several federal agencies through their prime vendor programs. The solicitation is projected for March 2023, though this date is subject to change. The acquisition is unrestricted, fully competitive, and for a commercial item.

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY (DLA) DLA TROOP SUPPORT
  PSC   DRUGS AND BIOLOGICALS


Data sourced from SAM.gov. View Official Posting »